Portman Square Capital »

Neurocrine Biosciences shares owned by Portman Square Capital

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Portman Square Capital from 13F filings

Historical chart of Portman Square Capital investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Portman Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Portman Square Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 131k 137.92
2023-12-31 $17M 131k 131.76

More positions owned by Portman Square Capital

Shift4 Pmts Cl A Put Option (FOUR)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Live Nation Entertainment (LYV)
Akamai Technologies Put Option (AKAM)
Middleby Corporation Put Option (MIDD)
Peabody Energy Put Option (BTU)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
American Airls Put Option (AAL)
Seagate Technology Hldngs Pl Ord Shs Put Option (STX)
Western Digital (WDC)
Metropcs Communications Put Option (TMUS)
Meta Platforms Cl A Call Option (META)
Cleveland-cliffs Call Option (CLF)
Micron Technology Put Option (MU)
Advanced Micro Devices Call Option (AMD)

View all positions for Portman Square Capital

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences